Department of Obstetrics and Gynecology, St, Marianna University School of Medicine, Kanagawa, Japan.
Thromb J. 2010 Nov 7;8:17. doi: 10.1186/1477-9560-8-17.
Patients with gynecologic cancer have a high risk of venous thromboembolism (VTE) like patients with other cancers. However, there is little information on risk factors for VTE during gynecologic surgery and no uniform preventive strategy. Our objectives were to identify risk factors for perioperative VTE in gynecologic patients and establish methods for prevention.
We analyzed 1,232 patients who underwent surgery at the Department of Obstetrics and Gynecology of St. Marianna University School of Medicine between January 2005 and June 2008. We investigated (1) risk factors for preoperative VTE, (2) use of an inferior vena cava (IVC) filter, and (3) risk factors for postoperative VTE.
There were 39 confirmed cases of perioperative VTE (3.17%), including 25 patients with preoperative VTE and 14 with postoperative VTE. Thirty-two patients had cancer and seven patients had benign diseases. Twenty-two of the 32 cancer patients (68.7%) had preoperative VTE, while postoperative VTE occurred in 10 cancer patients. Multivariate analysis indicated that ovarian cancer, tumor diameter ≥10 cm, and previous of VTE were independent risk factors for preoperative VTE. Among ovarian cancer patients, multivariate analysis showed that an age ≥50 years, the presence of heart disease, clear cell adenocarcinoma, and tumor diameter ≥20 cm were independent risk factors for preoperative VTE. The factors significantly related to preoperative VTE in patients with benign disease included previous VTE, age ≥55 years, tumor diameter ≥20 cm, and a history of allergic-immunologic disease. Thirteen of the 25 patients (52%) with preoperative VTE had an IVC filter inserted preoperatively. Postoperative screening (interview and D-dimer measurement) revealed VTE in 14/1,232 patients (1.14%). Multivariate analysis indicated that cancer surgery, a history of allergic-immunologic disease, and blood transfusion ≥2,000 ml were independent risk factors for postoperative VTE.
Perioperative VTE is often fatal and preventive measures should be taken in the gynecologic field, especially when patients have the risk factors identified in this study. Since VTE is often present before surgery, preoperative screening is important and use of an IVC filter should be considered.
妇科癌症患者与其他癌症患者一样,静脉血栓栓塞症(VTE)的风险较高。然而,关于妇科手术期间 VTE 的危险因素的信息很少,也没有统一的预防策略。我们的目的是确定妇科患者围手术期 VTE 的危险因素并建立预防方法。
我们分析了 2005 年 1 月至 2008 年 6 月期间在圣玛丽安娜大学医学院妇产科接受手术的 1232 名患者。我们调查了(1)术前 VTE 的危险因素,(2)使用下腔静脉(IVC)过滤器,以及(3)术后 VTE 的危险因素。
共有 39 例围手术期 VTE(3.17%),其中 25 例为术前 VTE,14 例为术后 VTE。32 例患者患有癌症,7 例患者患有良性疾病。32 例癌症患者中有 22 例(68.7%)患有术前 VTE,而 10 例癌症患者发生术后 VTE。多变量分析表明卵巢癌、肿瘤直径≥10cm 和 VTE 史是术前 VTE 的独立危险因素。在卵巢癌患者中,多变量分析表明年龄≥50 岁、心脏病、透明细胞腺癌和肿瘤直径≥20cm 是术前 VTE 的独立危险因素。良性疾病患者中与术前 VTE 显著相关的因素包括既往 VTE、年龄≥55 岁、肿瘤直径≥20cm 和过敏免疫性疾病史。25 例术前 VTE 患者中有 13 例(52%)术前插入了 IVC 过滤器。术后筛查(访谈和 D-二聚体测量)发现 1232 例患者中有 14 例(1.14%)发生 VTE。多变量分析表明癌症手术、过敏免疫性疾病史和输血≥2000ml 是术后 VTE 的独立危险因素。
围手术期 VTE 常是致命的,应在妇科领域采取预防措施,特别是当患者具有本研究确定的危险因素时。由于 VTE 常在手术前存在,因此术前筛查很重要,并且应考虑使用 IVC 过滤器。